Archive - November 2018
FDA Grants Priority Review for Daiichi Sankyo’s New Drug Application for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Chi-Med and Lilly’s cancer drug Elunate a milestone for China
Novartis gets EU nod for Luxturna gene therapy
EU27 backs Brexit terms – now the hard part starts for May
Schadenfreude: Why We Enjoy Other People’s Misery
FDA Approves The ACTpen for Actemra, A Single-Dose, Prefilled Autoinjector
4 Ill Effects Of Drinking Soda
What Is Anti-Inflammatory Diet And How It Benefits The Body